---
title: "Inorganic Antibacterial Solution Market, Global Outlook and Forecast 2025-2031"
datePublished: Thu Aug 21 2025 14:00:15 GMT+0000 (Coordinated Universal Time)
cuid: cmelgy262000x02jw9mer2eyd
slug: inorganic-antibacterial-solution-market-global-outlook-and-forecast-2025-2031

---

# Inorganic Antibacterial Solution Market, Global Outlook and Forecast 2025-2031

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global inorganic antibacterial solution market size was valued at USD 423 million in 2024. The market is projected to grow from USD 452 million in 2025 to USD 687 million by 2032, exhibiting a CAGR of 6.2% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/297124/inorganic-antibacterial-solution-market">
            https://www.24chemicalresearch.com/download-sample/297124/inorganic-antibacterial-solution-market</a></b></div><br><p>
</p><p>Inorganic antibacterial solutions are chemical formulations containing metallic ions such as silver, copper, or zinc that exhibit antimicrobial properties. These solutions work by disrupting microbial cell membranes and interfering with enzymatic processes, making them effective against a broad spectrum of bacteria, fungi, and viruses. The solutions are categorized into silver-based, copper-based, and zinc-based formulations.</p><p>
</p><p>The market growth is primarily driven by increasing hygiene awareness post-pandemic, stringent regulations in healthcare settings, and growing demand from textile and packaging industries. However, concerns about metal leaching and environmental impact pose challenges to market expansion. Key players like BASF, Microban, and DuPont are investing in nanoparticle technologies to develop more stable formulations with controlled ion release rates.</p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Rising Healthcare-Associated Infections Driving Adoption of Inorganic Antibacterial Solutions</strong></p><p>
</p><p>The global healthcare sector is witnessing an alarming rise in hospital-acquired infections (HAIs), creating urgent demand for effective antibacterial solutions. Recent data indicates HAIs affect over 7% of hospitalized patients in developed nations, with significantly higher rates in developing regions. Inorganic antibacterial agents, particularly silver-based formulations, have demonstrated 99.9% efficacy against multidrug-resistant pathogens like MRSA and CRE. This exceptional performance is accelerating adoption across medical devices, wound care products, and hospital surfaces. Furthermore, regulatory bodies are increasingly mandating antimicrobial protocols in healthcare facilities, creating sustained market growth opportunities.</p><p>
</p><p style="text-align:center"><strong>Expanding Applications in Consumer Goods Sector Boosting Market Expansion</strong></p><p>
</p><p>Consumer awareness about hygiene has surged post-pandemic, with 68% of global consumers now prioritizing antibacterial properties in everyday products. This behavioral shift is driving extraordinary demand for inorganic antibacterial solutions across textiles, personal care items, and household surfaces. The textile industry alone accounts for 32% of current market share, utilizing silver-ion technologies to create antimicrobial fabrics for sportswear, medical uniforms, and upholstery. Concurrently, the personal care sector is innovating with zinc-based formulations in cosmetic products, capitalizing on their dual antimicrobial and skin-protective benefits. Such diversified applications are creating multiple growth vectors for market players.</p><p>
</p><p style="text-align:center"><strong>Technological Advancements in Formulation Science Enhancing Market Potential</strong></p><p>
</p><p>Cutting-edge nanotechnology is revolutionizing inorganic antibacterial solutions by improving efficacy while reducing material requirements. Nano-silver formulations now demonstrate 40% greater antimicrobial activity compared to conventional solutions at equivalent concentrations. Simultaneously, innovations in controlled-release mechanisms are extending product longevity - a critical factor for applications like medical implants and building materials. Recent breakthroughs in copper-zinc composite formulations have also shown promise against viral pathogens, opening new avenues in pandemic preparedness. These technological strides are enabling manufacturers to develop differentiated, high-value products with superior performance characteristics.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>High Production Costs and Price Volatility of Raw Materials Limiting Market Penetration</strong></p><p>
</p><p>While demand grows exponentially, the inorganic antibacterial market faces significant cost barriers. Silver, accounting for 45% of all formulations, has experienced 28% price fluctuations in the past two years alone. These volatility patterns create budgeting challenges for manufacturers and price sensitivity in cost-conscious markets. Additionally, the energy-intensive production processes for nano-formulations contribute to premium pricing, restricting adoption in price-sensitive segments. Emerging economies, though promising growth markets, often opt for cheaper organic alternatives due to these cost constraints, slowing overall market expansion.</p><p>
</p><p style="text-align:center"><strong>Regulatory Scrutiny and Environmental Concerns Creating Adoption Hurdles</strong></p><p>
</p><p>Increasing environmental regulations present another challenge for market players. Several regions have imposed strict limits on heavy metal discharge, particularly for silver nanoparticles, due to aquatic ecosystem concerns. The European Chemicals Agency recently classified certain silver compounds as potential environmental hazards, triggering additional compliance requirements. Furthermore, the lack of standardized testing protocols across regions creates regulatory fragmentation, forcing manufacturers to navigate complex approval processes. These factors collectively increase time-to-market and R&amp;D costs, particularly for SMEs seeking market entry.</p><p>
</p><p style="text-align:center"><strong>Long-Term Efficacy Questions Impacting Consumer Confidence</strong></p><p>
</p><p>Market growth faces restraint from lingering questions about the durability of inorganic antibacterial effects. Independent studies show certain silver-based coatings lose 60% efficacy after repeated washing cycles in textile applications. This performance degradation, coupled with emerging bacterial resistance patterns, has prompted some healthcare providers to question long-term cost-benefit ratios. Manufacturers are addressing these concerns through advanced encapsulation technologies, but consumer education gaps persist. Until these efficacy concerns are fully mitigated, adoption rates may remain below potential in quality-sensitive applications.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Emerging Markets Present Significant Untapped Potential for Growth</strong></p><p>
</p><p>Developing economies represent the most promising frontier for market expansion, with healthcare infrastructure investments in Asia-Pacific growing at 11% annually. Countries like India and China are implementing national infection control programs that prioritize antimicrobial solutions in public health facilities. Simultaneously, rising disposable incomes are driving demand for premium consumer goods with antibacterial properties. Market penetration in these regions currently lags behind North America and Europe by 35-40%, indicating substantial headroom for growth. Strategic partnerships with local distributors and customized formulations for regional needs could unlock this potential.</p><p>
</p><p style="text-align:center"><strong>Food Safety Applications Opening New Revenue Streams</strong></p><p>
</p><p>The food industry is emerging as a high-growth sector for inorganic antibacterial solutions, with applications ranging from packaging to processing equipment. Recent foodborne illness outbreaks have prompted regulatory agencies to mandate stricter hygiene standards throughout the supply chain. Copper-based formulations are gaining traction in food contact surfaces, demonstrating superior performance against dangerous pathogens like E. coli and Salmonella. With global food packaging demand projected to increase by 28% over the next five years, antimicrobial solutions integrated into packaging materials represent a particularly lucrative opportunity for forward-thinking manufacturers.</p><p>
</p><p style="text-align:center"><strong>Strategic Collaborations Accelerating Product Innovation</strong></p><p>
</p><p>The market is witnessing a surge in cross-industry partnerships that combine material science expertise with application-specific knowledge. Leading chemical companies are collaborating with medical device manufacturers to develop next-generation antimicrobial coatings for implants and surgical tools. Similarly, partnerships between nanotechnology firms and textile producers are yielding fabrics with durable antibacterial properties. These synergistic relationships are shortening innovation cycles and creating products with superior market fit. The recent trend of academic-commercial research alliances is particularly promising, bridging the gap between laboratory breakthroughs and commercial applications.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Technical Limitations in Formulation Stability Hampering Certain Applications</strong></p><p>
</p><p>Despite significant advances, inorganic antibacterial solutions still face technical challenges in maintaining stability across diverse conditions. In high-temperature processing environments common to plastics manufacturing, many silver-based additives experience oxidation that reduces antimicrobial efficacy. Similarly, pH variations in cosmetic formulations can compromise zinc-based solutions. These technical constraints limit application scope and require costly formulation adjustments. While encapsulation technologies show promise in addressing these issues, their current premium pricing makes widespread adoption challenging outside high-value segments.</p><p>
</p><p style="text-align:center"><strong>Competition from Organic Alternatives Pressuring Market Share</strong></p><p>
</p><p>The market faces increasing competition from advanced organic antibacterial agents that offer easier regulatory pathways and perceived environmental benefits. New quaternary ammonium compounds and natural plant extracts are gaining market share in consumer applications where "chemical-free" positioning resonates with buyers. While inorganic solutions maintain superior performance in medical and industrial applications, the consumer sector sees growing substitution threats. This competitive pressure is forcing inorganic solution providers to invest heavily in public education about their safety profiles and environmental advancements.</p><p>
</p><p style="text-align:center"><strong>Supply Chain Vulnerabilities Creating Operational Risks</strong></p><p>
</p><p>Geopolitical factors and concentrated raw material sourcing present ongoing challenges for market stability. Over 65% of silver production originates from just three countries, creating potential supply disruptions. Recent trade policy shifts have already caused lead time extensions for critical inputs. Manufacturers are responding with strategies like strategic stockpiling and alternative material development, but these measures increase working capital requirements. The industry's transition to more sustainable sourcing practices, while beneficial long-term, currently involves complex supply chain restructuring that temporarily impacts production efficiency.</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Silver-Based Solutions Dominate Due to Broad-Spectrum Antibacterial Properties</strong></p><p>
</p><p>The market is segmented based on type into:</p><p>
</p><p>Silver-based solutions</p><p>
	</p><p>Subtypes: Ionic silver, Nano silver, and others</p><p>Copper-based solutions</p><p>Zinc-based solutions</p><p>Other metal-oxide solutions</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Textile Industry Leads Market Adoption for Hygiene-Focused Fabric Treatments</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Textile</p><p>Coating</p><p>Plastic</p><p>Cosmetic</p><p>Medical</p><p>
<strong>By End-User Industry</strong></p><p>
</p><p><strong>Healthcare Sector Shows Strong Demand for Antimicrobial Surface Protection</strong></p><p>
</p><p>The market is segmented by end-user industry into:</p><p>
</p><p>Healthcare</p><p>Consumer goods</p><p>Construction</p><p>Packaging</p><p>Water treatment</p><p>
  
<strong>Inorganic Antibacterial Solution Market - Competitive Landscape</strong>  </p><p>
<strong>Key Industry Players</strong>  </p><p>
</p><p style="text-align:center"><strong>Market Leaders Focus on Innovation and Strategic Expansion</strong></p><p>
</p><p>The global <strong>Inorganic Antibacterial Solution Market</strong>, valued at <strong>US$ 423 million in 2024</strong>, is projected to grow at a <strong>CAGR of 6.2%</strong> through 2032, reaching <strong>US$ 687 million</strong>. The competitive landscape is characterized by a mix of established chemical giants and niche manufacturers specializing in antibacterial additives, particularly <strong>silver</strong>, <strong>copper</strong>, and <strong>zinc-based solutions</strong>.</p><p>
</p><p><strong>BASF SE</strong> dominates the market with its diversified portfolio of silver-ion-based solutions, widely adopted in medical and plastic applications. The companyâs global supply chain and continuous R&amp;D investments reinforce its leadership, particularly in Europe and North America. Meanwhile, <strong>Microban International</strong> has carved a strong niche in textile and coating applications, leveraging patented antimicrobial technologies.</p><p>
</p><p>Japanese players like <strong>Toagosei Co., Ltd.</strong> and <strong>Ishizuka Glass Group</strong> are pivotal in advancing zinc-based solutions, catering to Asia-Pacificâs booming healthcare and electronics sectors. Their emphasis on <strong>eco-friendly formulations</strong> aligns with tightening environmental regulations, giving them an edge in sustainable markets.</p><p>
</p><p>Notably, <strong>Sciessent LLC</strong> and <strong>Milliken &amp; Company</strong> are aggressively expanding their market share through strategic acquisitions. Sciessentâs collaboration with textile manufacturers in India and Millikenâs focus on polymer-compatible solutions highlight the industryâs shift toward <strong>application-specific innovations</strong>.</p><p>
<strong>List of Prominent Companies in the Inorganic Antibacterial Solution Market</strong>  </p><p>
</p><p><strong>BASF SE</strong> (Germany)</p><p>Microban International (U.S.)</p><p>Toagosei Co., Ltd. (Japan)</p><p>Sciessent LLC (U.S.)</p><p>Milliken &amp; Company (U.S.)</p><p>DuPont de Nemours, Inc. (U.S.)</p><p>Pure Bioscience, Inc. (U.S.)</p><p>Ishizuka Glass Group (Japan)</p><p>Sanitized AG (Switzerland)</p><p>Sinanen Zeomic Co., Ltd. (Japan)</p><p>Addmaster (UK) Limited (U.K.)</p><p>Koa Glass Co., Ltd. (Japan)</p><p>
</p><p>Emerging players such as <strong>Addmaster</strong> (focusing on masterbatch solutions) and <strong>Fuji Chemical Industries</strong> (specializing in medical-grade antimicrobials) are gaining traction through localized production and rapid customization capabilities. However, competition intensifies as larger corporations invest in <strong>vertical integration</strong>, merging raw material supply with end-product development to reduce costs.</p><p>
</p><p>The marketâs progression hinges on technological advancements in <strong>nanotechnology</strong> and regulatory approvals for new formulations. Companies are also prioritizing collaborations with academic institutions to explore novel applications, particularly in <strong>wound care</strong> and <strong>food packaging</strong>, signaling a dynamic evolution in competitive strategies.</p><p>
<strong>INORGANIC ANTIBACTERIAL SOLUTION MARKET TRENDS</strong></p><p>
<strong>Rising Demand for Healthcare Hygiene Solutions to Drive Market Growth</strong></p><p>
</p><p>The global inorganic antibacterial solution market is experiencing robust growth, fueled by increasing awareness of hospital-acquired infections and stringent hygiene regulations across industries. With healthcare-associated infections affecting nearly 7% of patients in developed economies, antimicrobial coatings and treatments have become essential in medical equipment and facility maintenance. Silver-based solutions currently dominate the market with over 45% revenue share, owing to their broad-spectrum efficacy and stability compared to organic alternatives. Recent advancements in nanoparticle dispersion technologies have enhanced the performance of these solutions, allowing for longer-lasting antimicrobial effects on treated surfaces.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Expansion in Textile and Packaging Applications</strong></p><p>
</p><p>The textile industry represents one of the fastest-growing application segments for inorganic antibacterial solutions, projected to grow at 7.8% CAGR through 2032. Manufacturers are increasingly incorporating silver and zinc-based treatments into fabrics for medical scrubs, sportswear, and bedding products. Simultaneously, food packaging applications are gaining traction, with antimicrobial films demonstrating 99.9% effectiveness against common pathogens like E. coli and Staphylococcus aureus. This dual growth across consumer and industrial sectors is reshaping the competitive landscape of the market.</p><p>
<strong>Sustainable Formulation Development</strong></p><p>
</p><p>Environmental concerns are prompting manufacturers to develop eco-friendly inorganic antibacterial solutions without compromising efficacy. Copper-based formulations are emerging as sustainable alternatives, showing comparable antimicrobial performance to silver at lower production costs. Recent innovations include hybrid solutions combining inorganic actives with natural antimicrobials, reducing the required dosage by 30-40% while maintaining performance standards. Regulatory approvals for these next-generation formulations in the EU and North America are expected to accelerate market adoption in coming years.</p><p>
<strong>Asia-Pacific Market Expansion</strong></p><p>
</p><p>The Asia-Pacific region is witnessing the highest growth in inorganic antibacterial solution adoption, driven by expanding healthcare infrastructure and rising disposable incomes. Countries like China and India account for 38% of global demand, with local manufacturers investing heavily in production capacity. Government initiatives for infection control in public spaces post-pandemic have further bolstered market growth. Regional players are focusing on cost-effective solutions customized for tropical climates where microbial growth rates are 20-25% higher than temperate regions.</p><p>


<strong>Regional Analysis: Inorganic Antibacterial Solution Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
The inorganic antibacterial solution market in North America is driven by stringent healthcare regulations and a strong emphasis on infection control across medical and consumer applications. The U.S. dominates the regional market, accounting for over 70% of revenue share, with silver-based solutions being the most widely adopted due to their proven efficacy. Increasing demand from hospitals (especially antimicrobial coatings for medical equipment) and the personal care industry is accelerating growth. However, high production costs and supply chain complexities restrain the marketâs full potential. Recent FDA approvals for inorganic antibacterial additives in medical devices are expected to further boost adoption.</p><p>
</p><p><strong>Europe</strong></p><p>
Europeâs market is characterized by rigorous regulatory oversight under the EU Biocidal Products Regulation (BPR), which mandates extensive testing for antibacterial solutions. Germany and France lead in R&amp;D investments for eco-friendly inorganic antimicrobial agents, particularly zinc- and copper-based formulations. The regionâs packaging industry has been a key adopter, leveraging antibacterial solutions to extend product shelf life. While demand is steady, growth is moderated by the preference for organic alternatives in some consumer segments. Sustainability-focused innovations, such as recyclable antimicrobial plastics, are gaining traction.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
This region is the fastest-growing market, projected to expand at a CAGR of 7.3% through 2032, with China and India as primary contributors. Rapid industrialization and increasing health awareness are driving demand across textiles, plastics, and construction materials. Cost-effectiveness makes zinc-based solutions popular, though silver variants dominate premium medical applications. Challenges include inconsistent regulatory standards and price sensitivity. Japanâs advanced healthcare sector and South Koreaâs thriving electronics industry (antibacterial coatings for devices) present high-value opportunities for specialized solutions.</p><p>
</p><p><strong>South America</strong></p><p>
Market development here is uneven, with Brazil accounting for nearly 50% of regional demand, primarily in medical and packaging sectors. Economic instability affects investments in advanced antibacterial technologies, pushing manufacturers toward low-cost alternatives. Infrastructure limitations in testing facilities delay product approvals, slowing market entry for global players. However, rising disposable incomes and urbanization are gradually increasing demand for antibacterial-treated consumer goods. Local production remains limited, creating import dependence.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
The market is in a growth phase, with the UAE and Saudi Arabia leading due to healthcare infrastructure expansions and tourism-driven demand for hygienic surfaces. Silver-based solutions are preferred despite higher costs because of their broad-spectrum efficacy. Africaâs market is constrained by low purchasing power and inadequate distribution networks, though increasing FDI in healthcare is creating pockets of opportunity. The lack of localized regulations results in varying product quality standards across countries.</p><p>

<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Inorganic Antibacterial Solution, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Inorganic Antibacterial Solution companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Inorganic Antibacterial Solution Market?</strong></p><p>
</p><p><strong>-&gt;</strong> The Global Inorganic Antibacterial Solution market was valued at <strong>USD 423 million in 2024</strong> and is projected to reach <strong>USD 687 million by 2032</strong>, growing at a <strong>CAGR of 6.2%</strong> during 2025-2032.</p><p>
<strong>Which key companies operate in Global Inorganic Antibacterial Solution Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>BASF, Microban, Toagosei, Sciessent, Milliken, DuPont, Pure Bioscience, Ishizuka Glass Group, Sanitized, and Sinanen Zeomic</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand for antimicrobial solutions in healthcare, increasing hygiene awareness post-pandemic, and growing applications in textiles, plastics, and coatings</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; Asia-Pacific</strong> is the fastest-growing region due to industrialization and healthcare investments, while <strong>North America</strong> holds the largest market share.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>nano-based antibacterial solutions, eco-friendly formulations, and increased R&amp;D in medical-grade applications</strong>.</p><p>
</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/297124/inorganic-antibacterial-solution-market">
            https://www.24chemicalresearch.com/reports/297124/inorganic-antibacterial-solution-market</a></b></div><br>
            <b>Table of Content:</b><p>1 Introduction to Research & Analysis Reports<br />
 1.1 Inorganic Antibacterial Solution Market Definition<br />
 1.2 Market Segments<br />
 1.2.1 Segment by Type<br />
 1.2.2 Segment by Application<br />
 1.3 Global Inorganic Antibacterial Solution Market Overview<br />
 1.4 Features & Benefits of This Report<br />
 1.5 Methodology & Sources of Information<br />
 1.5.1 Research Methodology<br />
 1.5.2 Research Process<br />
 1.5.3 Base Year<br />
 1.5.4 Report Assumptions & Caveats<br />
2 Global Inorganic Antibacterial Solution Overall Market Size<br />
 2.1 Global Inorganic Antibacterial Solution Market Size: 2024 VS 2031<br />
 2.2 Global Inorganic Antibacterial Solution Market Size, Prospects & Forecasts: 2020-2031<br />
 2.3 Global Inorganic Antibacterial Solution Sales: 2020-2031<br />
3 Company Landscape<br />
 3.1 Top Inorganic Antibacterial Solution Players in Global Market<br />
 3.2 Top Global Inorganic Antibacterial Solution Companies Ranked by Revenue<br />
 3.3 Global Inorganic Antibacterial Solution Revenue by Companies<br />
 3.4 Global Inorganic Antibacterial Solution Sales by Companies<br />
 3.5 Global Inorganic Antibacterial Solution Price by Manufacturer (2020-2025)<br />
 3.6 Top 3 and Top 5 Inorganic Antibacterial Solution Companies in Global Market, by Revenue in 2024<br />
 3.7 Global Manufacturers Inorganic Antibacterial Solution Product Type<br />
 3.8 Tier 1, Tier 2, and Tier 3 Inorganic Antibacterial Solution Players in Global Market<br />
 3.8.1 List of Global Tier 1 Inorganic Antibacterial Solution Companies<br />
 3.8.2 List of Global Tier 2 and Tier 3 Inorganic Antibacterial Solution Companies</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/297124/inorganic-antibacterial-solution-market">
            https://www.24chemicalresearch.com/reports/297124/inorganic-antibacterial-solution-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>